NCT00725465

Brief Summary

The purpose of this study is to evaluate prospectively the usefulness of IC-CO2(intraoperative colonoscopy (IC) using carbon dioxide (CO2)) in colon and rectal surgical practice, coincident with laparoscopic surgery, and assess whether it provides useful information that influences the type of surgical therapy intended. Investigators will further define the safety and extent of bowel distension when using IC-CO2.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 30, 2008

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

July 30, 2019

Status Verified

July 1, 2019

Enrollment Period

2.4 years

First QC Date

July 24, 2008

Last Update Submit

July 26, 2019

Conditions

Keywords

laparoscopyCO2 colonoscopyintraoperative CO2 colonoscopycombined Lap-CO2 procedure

Outcome Measures

Primary Outcomes (1)

  • arterial blood gas (ABG)

    30 days

Study Arms (1)

LAP surgery with CO2 colonoscopy

30 surgical patients, male and female undergoing laparoscopic surgical treatment for colorectal conditions such as neoplasm or rectal prolapse managed with intra-operative carbon dioxide (co2)colonoscopy for standard care of their medical condition.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

30 surgical patients, male and female undergoing laparoscopic surgical treatment for colorectal conditions such as neoplasm or rectal prolapse managed with intra-operative carbon dioxide (co2)colonoscopy for standard care of their medical condition. Multiple measurments of Arterial Blood Gass will be performed and evaluated.

You may qualify if:

  • All patients (male and female) greater than 18 years of age who undergo a laparoscopic surgical procedure that utilizes intra-operative colonoscopy will be approached to participate in this study

You may not qualify if:

  • Patients under 18 year of age
  • Patients with severe Renal Diseases
  • Ascites
  • COPD (severe)
  • Liver insufficiency (severe) with coagulopathy
  • Dialysis
  • Sleep Apnea
  • Patient pregnant
  • Multiple previous surgeries
  • Subject is incapable of understanding the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Medical College

New York, New York, 10065, United States

Location

Related Links

Study Officials

  • Jeffrey W Milsom, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2008

First Posted

July 30, 2008

Study Start

January 1, 2006

Primary Completion

June 1, 2008

Study Completion

December 1, 2010

Last Updated

July 30, 2019

Record last verified: 2019-07

Locations